Literature DB >> 19380712

A new function of the Fas-FasL pathway in macrophage activation.

Reza Chakour1, Cindy Allenbach, Florian Desgranges, Mélanie Charmoy, Jacques Mauel, Irène Garcia, Pascal Launois, Jacques Louis, Fabienne Tacchini-Cottier.   

Abstract

Upon infection with the protozoan parasite Leishmania major, susceptible BALB/c mice develop unhealing lesions associated with the maturation of CD4(+)Th2 cells secreting IL-4. In contrast, resistant C57BL/6 mice heal their lesions, because of expansion and secretion of IFN-gamma of CD4(+) Th1 cells. The Fas-FasL pathway, although not involved in Th cell differentiation, was reported to be necessary for complete resolution of lesions. We investigate here the role of IFN-gamma and IL-4 on Fas-FasL nonapoptotic signaling events leading to the modulation of macrophage activation. We show that addition of FasL and IFN-gamma to BMMø led to their increased activation, as reflected by enhanced secretion of TNF, IL-6, NO, and the induction of their microbicidal activity, resulting in the killing of intracellular L. major. In contrast, the presence of IL-4 decreased the synergy of IFN-gamma/FasL significantly on macrophage activation and the killing of intracellular L. major. These results show that FasL synergizes with IFN-gamma to activate macrophages and that the tight regulation by IFN-gamma and/or IL-4 of the nonapoptotic signaling events triggered by the Fas-FasL pathway affects significantly the activation of macrophages to a microbicidal state and may thus contribute to the pathogenesis of L. major infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380712     DOI: 10.1189/jlb.1008590

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  13 in total

1.  Immune consequences of tyrosine kinase inhibitors that synergize with cancer immunotherapy.

Authors:  Anna R Kwilas; Renee N Donahue; Kwong Y Tsang; James W Hodge
Journal:  Cancer Cell Microenviron       Date:  2015

2.  Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.

Authors:  Tiffany Weinkopff; Anita Mariotto; Gregoire Simon; Yazmin Hauyon-La Torre; Floriane Auderset; Steffen Schuster; Haroun Zangger; Nicolas Fasel; Aldina Barral; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

3.  Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity.

Authors:  Catriona A Wagner; Pamela J Roqué; Trevor R Mileur; Denny Liggitt; Joan M Goverman
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

4.  Inhibition of caspase-8 activity promotes protective Th1- and Th2-mediated immunity to Leishmania major infection.

Authors:  Wânia F Pereira-Manfro; Flávia L Ribeiro-Gomes; Alessandra Almeida Filardy; Natália S Vellozo; Landi V C Guillermo; Elisabeth M Silva; Richard M Siegel; George A Dosreis; Marcela F Lopes
Journal:  J Leukoc Biol       Date:  2013-09-26       Impact factor: 4.962

Review 5.  γδ T Cells and dendritic cells in refractory Lyme arthritis.

Authors:  Ali Divan; Ralph C Budd; Richard P Tobin; M Karen Newell-Rogers
Journal:  J Leukoc Biol       Date:  2015-01-20       Impact factor: 4.962

6.  Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines.

Authors:  Benedetto Farsaci; Renee N Donahue; Michael A Coplin; Italia Grenga; Lauren M Lepone; Alfredo A Molinolo; James W Hodge
Journal:  Cancer Immunol Res       Date:  2014-08-04       Impact factor: 11.151

7.  Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.

Authors:  Geremew Tasew; Susanne Nylén; Thorsten Lieke; Befekadu Lemu; Hailu Meless; Nicolas Ruffin; Dawit Wolday; Abraham Asseffa; Hideo Yagita; Sven Britton; Hannah Akuffo; Francesca Chiodi; Liv Eidsmo
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

8.  Splenectomy promotes indirect elimination of intraocular tumors by CD8+ T cells that is associated with IFNγ- and Fas/FasL-dependent activation of intratumoral macrophages.

Authors:  Maxine R Miller; Jonathan B Mandell; Kelly M Beatty; Stephen A K Harvey; Michael J Rizzo; Dana M Previte; Stephen H Thorne; Kyle C McKenna
Journal:  Cancer Immunol Res       Date:  2014-09-23       Impact factor: 11.151

9.  Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts.

Authors:  Joshua C Doloff; David J Waxman
Journal:  BMC Cancer       Date:  2015-05-08       Impact factor: 4.430

10.  In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.

Authors:  Iotefa Teiti; Bertrand Florie; Christine Pich; Rémi Gence; Isabelle Lajoie-Mazenc; Philippe Rochaix; Gilles Favre; Anne-Françoise Tilkin-Mariamé
Journal:  Front Oncol       Date:  2015-07-14       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.